Page 215 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Classification and Pathogenicity of ANCA-Associated Vasculitis 191

[35] Gayraud, M., Guillevin, L., Toumelin, P., et al. Long-term followup of polyarteritis
nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four
prospective trials including 278 patients. Arthritis Rheum. 2001; 44:666-675.

[36] Lhote, F., Cohen, P., Guillevin, L. Polyarteritis nodosa, microscopic polyangiitis and
Churg-Strauss syndrome. Lupus 1998; 7:238-258.

[37] Pagnoux, C., Mahr, A., Cohen, P., et al. Presentation and outcome of gastrointestinal
involvement in systemic necrotizing vasculitides: analysis of 62 patients with
polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss
syndrome, or rheumatoid arthritis-associated vasculitis. Medicine 2005; 84:115-128.

[38] Shiina, T., Inoko, H., Kulski, J. K. An update of the HLA genomic region, locus
information and disease associations: 2004. Tissue Antigens 2004; 64:631-649.

[39] Stassen, P. M., Cohen-Tervaert, J. W., Lems, S. P., et al. HLA-DR4, DR13(6) and the
ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and
Wegener's granulomatosis. Rheumatology 2009; 48:622-625.

[40] Tsuchiya, N., Kobayashi, S., Kawasaki, A., et al. Genetic background of Japanese
patients with antineutrophil cytoplasmic antibody-associated vasculitis: association of
HLA-DRB1*0901 with microscopic polyangiitis. J. Rheumatol. 2003; 30:1534-1540.

[41] Cao, Y., Schmitz, J. L., Yang, J., et al. DRB1*15 allele is a risk factor for PR3-ANCA
disease in African Americans. J. Am. Soc. Nephrol. 2011; 22:1161-1167.

[42] Fanciulli, M., Norsworthy, P. J., Petretto, E., et al. FCGR3B copy number variation is
associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat.
Genet. 2007; 39:721-723.

[43] Kamesh, L., Heward, J. M., Williams, J. M., et al. CT60 and +49 polymorphisms of
CTLA 4 are associated with ANCA-positive small vessel vasculitis. Rheumatology
2009; 48:1502-1505.

[44] Wieczorek, S., Hoffjan, S., Chan, A., et al. Novel association of the CD226 (DNAM-1)
Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple
sclerosis in German patients. Genes Immun. 2009; 10:591-595.

[45] Carr, E. J., Niederer, H. A., Williams, J., et al. Confirmation of the genetic association
of CTLA4 and PTPN22 with ANCA-associated vasculitis. BMC Med. Genet. 2009; 10:
121.

[46] Martorana, D., Maritati, F., Malerba, G., et al. A. PTPN22 R620W polymorphism in the
ANCA-associated vasculitides. Rheumatology 2012; 51:805-812.

[47] Zhou, X. J., Cheng, F. J., Lv, J. C., et al. Higher DEFB4 genomic copy number in SLE
and ANCA-associated small vasculitis. Rheumatology 2012; 51:992-995.

[48] McKinney, E. F., Lyons, P. A., Carr, E. J., et al. A CD8+ T cell transcription signature
predicts prognosis in autoimmune disease. Nat. Med. 2010; 16:586-591.

[49] Baslund, B., Szpirt, W., Eriksson, S., et al. Complexes between proteinase 3, alpha 1-
antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison
between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's
granulomatosis. Eur. J. Clin. Invest. 1996; 26:786-792.

[50] Callea, F., Gregorini, G., Sinico, A., et al. Alpha 1-Antitrypsin (AAT) deficiency and
ANCA-positive systemic vasculitis: genetic and clinical implications. Eur. J. Clin.
Invest. 1997; 27:696-702.

Complimentary Contributor Copy